Home LiteratureArticle Details
PMID: 21571140 Published · ppublish English Comment Letter

Aspirin in the prevention of cancer.

Lancet (London, England) ·Vol. 377 ·No. 9778 ·2011-05-14 ·Pages 1650-1; author reply 1651-2

Nelson M

Abstract

暂无摘要

MeSH Terms
Age Factors Anticarcinogenic Agents/administration & dosage,adverse effects Aspirin/administration & dosage,adverse effects Clinical Trials as Topic Gastrointestinal Hemorrhage/chemically induced Humans Neoplasms/prevention & control Stroke/chemically induced
Chemicals
Anticarcinogenic Agents Aspirin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Nelson Mark
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
1474-547X
DOI
10.1016/S0140-6736(11)60668-5
Published
2011-05-14
Pages
1650-1; author reply 1651-2
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentOn
PMID: 21144578
External Links
PubMed source DOI: 10.1016/S0140-6736(11)60668-5 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2